COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications Layal Al MahmasaniMohammad Hassan HodrojAli Taher Review Article 01 February 2021 Pages: 1115 - 1122
Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies Yujia ZhangRachael GarnerDominique Duncan Review Article 08 March 2021 Pages: 1123 - 1132
Opioids are not a major cause of death of patients with sickle cell disease Samir K. Ballas Original Article 23 March 2021 Pages: 1133 - 1138
Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network Alessia PepeMichele RizzoAntonella Meloni Original Article 19 March 2021 Pages: 1139 - 1147
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study Tatiana RaskovalovaMarie-Christine JacobJosé Labarère Original Article 10 February 2021 Pages: 1149 - 1158
Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy Olivier BalloFagr EladlyChristian H. Brandts Original Article Open access 11 March 2021 Pages: 1159 - 1167
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort Magdalena M. BruneGeorg Stüssion behalf of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) Original Article Open access 02 March 2021 Pages: 1169 - 1179
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial Michael HeuserB. Douglas SmithJorge E. Cortes Original Article Open access 19 March 2021 Pages: 1181 - 1194
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients Andrius ZucenkaKazimieras ManeikisLaimonas Griskevicius Original Article 04 March 2021 Pages: 1195 - 1202
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center Wenbing DuanXiaohong LiuHao Jiang Original Article 20 January 2021 Pages: 1203 - 1212
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients Emilia ScalzulliGiovanni CaocciMassimo Breccia Original Article 07 March 2021 Pages: 1213 - 1219
Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement Moo-Kon SongJoo-Seop ChungSeok-Mo Lee Original Article 25 March 2021 Pages: 1221 - 1229
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma Pablo MozasAndrea RiveroArmando López-Guillermo Original Article 25 February 2021 Pages: 1231 - 1239
Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma Davide IppolitoTeresa GiandolaSandro Sironi Original Article 04 March 2021 Pages: 1241 - 1249
The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma Yuanyuan JinXiaochen YuJunling Zhuang Original Article 08 March 2021 Pages: 1251 - 1260
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world” Hira S. MianMark A. FialaTanya M. Wildes Original Article 21 January 2021 Pages: 1261 - 1266
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation Jing LiuXiao-Hui ZhangXiao-Dong Mo Original Article 13 March 2021 Pages: 1267 - 1281
Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation Małgorzata Salamonowicz-BodziochJowita FrączkiewiczJan Styczyński Original Article Open access 04 March 2021 Pages: 1283 - 1293
Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide Naoki KuritaTatsuhiro SakamotoShigeru Chiba Original Article 12 February 2021 Pages: 1295 - 1301
Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival Juan TongLei ZhangZimin Sun Original Article Open access 20 January 2021 Pages: 1303 - 1309
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation Arjun Datt LawSita BhellaDennis Dong Hwan Kim Original Article 12 March 2021 Pages: 1311 - 1319
High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease Souichi ShiratoriHiroyuki OhigashiTakanori Teshima Original Article 19 November 2020 Pages: 1321 - 1328
Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion Mirei HoriuchiMasahiro YoshidaTakahisa Yamane Letter to the Editor 05 November 2020 Pages: 1329 - 1331
Venetoclax-induced panniculitis in an acute myeloid leukemia patient Po-Wei LiaoRen Ching WangChieh-Lin Jerry Teng Letter to the Editor 13 January 2021 Pages: 1333 - 1334
Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera Ivan KrečakHrvoje HolikMarko Lucijanić Letter to the Editor 20 January 2021 Pages: 1335 - 1336
Clonal derivation of sequential seminoma and acute megakaryoblastic leukaemia Karen H. K. TangAlvin H. W. IpYok-Lam Kwong Letter to the Editor 24 March 2021 Pages: 1337 - 1339
A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor Ken SasakiKensuke MatsudaMineo Kurokawa Letter to the Editor 30 March 2021 Pages: 1341 - 1343
Fatal splenic rupture after discontinuing treatment by ibrutinib and venetoclax in relapse/refractory mantle cell lymphoma Louise RoulinCorinne HaiounFrançois Lemonnier Letter to the Editor 02 March 2021 Pages: 1345 - 1347
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity? Claire SeydouxJakob R. PasswegMichael Medinger Letter to the Editor 10 March 2021 Pages: 1349 - 1350
Daratumumab for refractory warm autoimmune hemolytic anemia Ankur JainD. K. Gupta Letter to the Editor 14 May 2020 Pages: 1351 - 1353
dsDNA from extracellular vesicles (EVs) in adult AML Simona BernardiC. ZanaglioD. Russo Letter to the Editor Open access 30 May 2020 Pages: 1355 - 1356
Rosette-like formation in multiple myeloma Masanori AokiNaoki TakahashiYasuhiro Ebihara Letter to the Editor 07 May 2020 Pages: 1357 - 1358